Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination

Replication-incompetent adenoviral vectors have been extensively used as a platform for vaccine design, with at least four anti-COVID-19 vaccines authorized to date. These vaccines elicit neutralizing antibody responses directed against SARS-CoV-2 Spike protein and confer significant level of protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Byazrova, Maria G., Astakhova, Ekaterina A., Minnegalieva, Aygul R., Sukhova, Maria M., Mikhailov, Artem A., Prilipov, Alexey G., Gorchakov, Andrey A., Filatov, Alexander V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665038/
https://www.ncbi.nlm.nih.gov/pubmed/36379998
http://dx.doi.org/10.1038/s41541-022-00566-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665038/
https://www.ncbi.nlm.nih.gov/pubmed/36379998
http://dx.doi.org/10.1038/s41541-022-00566-x

Ejemplares similares